Expanded testing panel provides a better understanding of a patient’s genetic medication risk profile. Genomind’s real-time, interactive, medication management tool GenMedPro™ has expanded to include ...

PHILADELPHIA--(BUSINESS WIRE)-- Audacy announced a multiplatform partnership with mental health innovator Genomind. This breakthrough partnership taps into Audacy’s influencers and Genomind’s ...

Genomind’s pharmacogenetic testing, which is transforming the landscape of precision medicine, uses a simple cheek swab to assess genes that influence drug metabolism, tolerability, and efficacy. The ...

GLEN ALLEN, Va., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the ...

MOORESTOWN, N.J.--(BUSINESS WIRE)--Cosán, a provider of technology-driven preventative care services for older adults and the physicians that support them, and Genomind, a leading precision healthcare ...

Partnership has successfully completed analytical validation of a cheek swab collection solution for testing and identifying patients with the genotypes important for AD04 development GLEN ALLEN, Va., ...